Skip to Content

W 926 (ENALAPRIL 20 mg)

Pill imprint W 926 has been identified as Enalapril maleate 20 mg.

Enalapril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; hypertensive emergency; left ventricular dysfunction (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 20 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Enalapril maleate 20 mg W 926
Enalapril maleate 20 mg W 926  Front
Enalapril maleate 20 mg W 926  Back
Enalapril maleate 20 mg W 926
Enalapril maleate
W 926
20 mg
8.00 mm
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Wockhardt USA
National Drug Code (NDC):
Inactive Ingredients:
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00172-4198 Ivax Pharmaceuticals Inc
68084-0392 Amerisource Health Services
00904-5611 Major Pharmaceuticals
63304-0837 Ranbaxy Pharmaceuticals Inc.
63874-0987 Altura Pharmaceuticals Inc (repackager)
54569-5135 A-S Medication Solutions, LLC (repackager)
55887-0227 Diversified Healthcare Services Inc (repackager)
23490-5492 Palmetto State Pharmaceuticals Inc (repackager)
33358-0128 CorePharma, LLC (repackager)
21695-0489 Rebel Distributors Corp (repackager)
66336-0393 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.